2000
DOI: 10.1006/abio.2000.4755
|View full text |Cite
|
Sign up to set email alerts
|

Detection of Genetic Point Mutations by Peptide Nucleic Acid-Mediated Polymerase Chain Reaction Clamping Using Paraffin-Embedded Specimens

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2003
2003
2020
2020

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(5 citation statements)
references
References 9 publications
0
5
0
Order By: Relevance
“…As far as sensitivity is concerned, most of the various methods can detect somewhere in the range of one mutant allele in the presence of approximately a 1000fold excess of normal alleles. 30,47,51 The highest sensitivity was reported by Sun and colleagues, 52 who were able to detect as few as 3 mutant alleles in the presence of 10,000 normal alleles. Our results are within this range, the method consistently allowing detection of at least 1 mutant allele among 2000 normal alleles, in some cases we were able to identify 1 mutant allele among 20,000 normal alleles.…”
Section: Discussionmentioning
confidence: 98%
“…As far as sensitivity is concerned, most of the various methods can detect somewhere in the range of one mutant allele in the presence of approximately a 1000fold excess of normal alleles. 30,47,51 The highest sensitivity was reported by Sun and colleagues, 52 who were able to detect as few as 3 mutant alleles in the presence of 10,000 normal alleles. Our results are within this range, the method consistently allowing detection of at least 1 mutant allele among 2000 normal alleles, in some cases we were able to identify 1 mutant allele among 20,000 normal alleles.…”
Section: Discussionmentioning
confidence: 98%
“…Shiu et al [3], for the first time demonstrated the mechanism of action of PIP in breast cancer development, which is mediated by over-expression of prolactin. The peptide based nucleotide method (highly sensitive) has clearly established a marked relation between PIP expression and breast cancer development [98]. In earlier days, PIP was considered a biomarker only for breast cancer because in immunohistochemical analysis and in-situ mRNA hybridization experiments, it had been observed that the mRNA of PIP was not detected in a small number of human tumors such as prostate, bladder, colon, uterus, thyroid, and kidney cancer, however, it was detected only in some benign breast tissue [1,99].…”
Section: Tumor Progression and Biomarkermentioning
confidence: 99%
“…PNA can also bind specific dsDNA targets by triplex formation, even in biological buffers that suppress triplex formation between ssDNA and dsDNA ( , ). Leveraging these unique DNA-binding properties, PNAs have been implemented in platforms for DNA sensing ( ) and separation ( ), primarily by linking PNAs to solid surfaces or fluorophores.…”
Section: Introductionmentioning
confidence: 99%